OpGen
In Brief This Week: Illumina, 10x Genomics, Thermo Fisher, Natera, Complete Genomics, More
News items for the week of Nov. 13, 2023
OpGen Subsidiaries Curetis, Ares Genetics File for Bankruptcy
The bankruptcy proceedings come after OpGen's unsuccessful attempts to sell Curetis and Ares Genetics or their assets.
OpGen Shares Skyrocket on $1M Private Placement Plans
The molecular diagnostic developer announced that it would raise $1.0 million as part of a private placement with an investor.
In Brief This Week: MiRxes, Oncocyte, OpGen, Biodesix, Element Biosciences, More
News items for the week of Aug. 7, 2023
Curetis, FIND Extend Antimicrobial Resistance Research Collaboration
The extended partnership covers the development of an AMR assay, a cartridge for the Unyvero A30 platform, and a software plug-in.
May 2, 2023
OpGen Prices $3.5M Public Offering
Jan 10, 2023
MDx Firm OpGen Prices $7.5M Public Offering
Jan 5, 2023
OpGen Announces 1-for-20 Reverse Stock Split
Sep 30, 2022